Item Posts Archive - Page 27 of 1770 - Medivizor
Navigation Menu

Evaluating the effectiveness of a luteinizing hormone-based modified GnRH antagonist protocol in patients with normal ovarian response undergoing in vitro fertilization treatment.

Evaluating the effectiveness of a luteinizing hormone-based modified GnRH antagonist protocol in patients with normal ovarian response undergoing in vitro fertilization treatment.

Posted by on Feb 28, 2023 in Infertility | 0 comments

In a nutshell This study evaluated the clinical and cost-effectiveness of a luteinizing hormone (LH)-based modified gonadotrophin-releasing hormone (GnRH) antagonist protocol in patients with normal ovarian response undergoing in vitro fertilization (IVF) treatment. The data showed that the LH-based modified GnRH antagonist protocol was more...

Read More

Evaluating the risk of cardiovascular disease mortality among long-term survivors of classical Hodgkin lymphoma.

Evaluating the risk of cardiovascular disease mortality among long-term survivors of classical Hodgkin lymphoma.

Posted by on Feb 28, 2023 in Hodgkin's lymphoma | 0 comments

In a nutshell This study evaluated the risk of cardiovascular disease mortality among long-term survivors of classical Hodgkin lymphoma (cHL). The data showed that patients with early-stage HL are at a higher risk of mortality from cardiovascular disease than from cancer. Some background cHL is a cancer that starts in white blood cells called...

Read More

Evaluating the effectiveness and safety of zanubrutinib versus ibrutinib in patients with Waldenström Macroglobulinemia.

Evaluating the effectiveness and safety of zanubrutinib versus ibrutinib in patients with Waldenström Macroglobulinemia.

Posted by on Feb 28, 2023 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study evaluated the effectiveness and safety of zanubrutinib (Brukinsa) versus ibrutinib (Imbruvica) in patients with Waldenström Macroglobulinemia (WM). The data showed that zanubrutinib had higher long-term response rates and lower side effects than ibrutinib in these patients. Some background WM is a type of cancer in which...

Read More

Evaluating the effectiveness of lenalidomide-containing triplet regimens in patients with first relapsed multiple myeloma.

Evaluating the effectiveness of lenalidomide-containing triplet regimens in patients with first relapsed multiple myeloma.

Posted by on Feb 28, 2023 in Multiple Myeloma | 0 comments

In a nutshell This study evaluated the effectiveness of lenalidomide (Revlimid)-containing regimens in patients with first relapsed multiple myeloma (MM). The data showed that daratumumab (Darzalex) combined with lenalidomide and dexamethasone (Rd) regimen significantly increased the survival without cancer worsening with fewer serious side effects...

Read More

Evaluating the effectiveness of acupuncture for the treatment of anxiety in patients with Parkinson’s disease.

Evaluating the effectiveness of acupuncture for the treatment of anxiety in patients with Parkinson’s disease.

Posted by on Feb 28, 2023 in Parkinson's Disease | 0 comments

In a nutshell This study evaluated the effectiveness of acupuncture for the treatment of anxiety in patients with Parkinson’s disease (PD). The data showed that acupuncture was an effective treatment for anxiety and improved the well-being of these patients. Some background Parkinson's disease (PD) is a disorder in which part of the brain is...

Read More
ABOUT USHOW IT WORKSBLOG NEWS PARTNERS CONTACT US PRIVACY POLICY TERMS OF USE
FROM OUR BLOG
LATEST NEWS
CONNECT WITH US
© 2024 Medivizor